 |
|
|
| |
RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAgpositive and negative patients with chronic HBV
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Man-Fung Yuen1, Kevin Liu1, Bruce D. Given2, Thomas Schluep2, James Hamilton2, Ching-Lung Lai1, Stephen A. Locarnini3, Kathy Jackson3, Johnson YN Lau1,4, Carlo Ferrari5, Robert G. Gish6,7
1 The University of Hong Kong, Hong Kong, China 2 Arrowhead Pharmaceuticals Inc., Pasadena, CA, USA; 3 Victorian InfectiousDiseases Reference Laboratory, Victoria, Australia; 4 Hong Kong Polytechnic University, Hong Kong, China; 5 University of Parma, Parma, Italy;6Stanford University, Palo Alto, CA, USA; 7 Hepatitis B Foundation, Doylestown, PA, USA
HBV-New Approach May be Needed - (10/16/17)
http://www.natap.org/2017/HBV/eaan0241.full.pdf
|
| |
|
|
|
|
|
